Home › Funds › TRAPHAGEN INVESTMENT ADVISORS LLC › SCHD

TRAPHAGEN INVESTMENT ADVISORS LLC position in SCHD

SCHWAB STRATEGIC TR

TRAPHAGEN INVESTMENT ADVISORS LLC reported holding 387,252 shares of SCHD (SCHWAB STRATEGIC TR) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 0.86% of its reported portfolio and ranking #22 among its reported holdings. TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed SCHD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)387.25K sh
Reported value held$12.60M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeAdd
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How TRAPHAGEN INVESTMENT ADVISORS LLC's SCHD position evolved

TRAPHAGEN INVESTMENT ADVISORS LLC first disclosed a stake in SCHD in Q3 2023 at 264,324 shares (US$18.7M). Across 13 filings, TRAPHAGEN INVESTMENT ADVISORS LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 387,252 shares valued at US$12.6M — an increase of 108,892 shares quarter over quarter.. Notable position changes include a 85% trim in Q1 2024 (shares fell 4% over the following quarter), a 121% increase in Q4 2024 (shares rose 2% over the following quarter), a 272% increase in Q1 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 264.32K $18.70M New
Q4 2023 155.36K $11.83M Reduce
Q1 2024 23.40K $1.89M Reduce
Q2 2024 15.03K $1.17M Reduce
Q3 2024 12.97K $1.10M Reduce
Q4 2024 28.71K $784.37K Add
Q1 2025 29.26K $818.00K Add
Q2 2025 30.51K $808.46K Add
Q3 2025 39.57K $1.08M Add
Q4 2025 61.70K $1.69M Add
Q1 2026 229.77K $7.05M Add
Q2 2026 278.36K $8.83M Add
Q3 2026 387.25K $12.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SCHD and 13F data

SCHD (SCHWAB STRATEGIC TR) is a company whose sector is not yet classified in our data. 27 other funds we track also report a position in SCHD — the largest reported positions include SUMITOMO LIFE INSURANCE CO (US$1.89B), Rakuten Investment Management, Inc. (US$1.66B), Cetera Investment Advisers (US$808.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SCHD

All SCHD fund holders →

FAQ

How long has TRAPHAGEN INVESTMENT ADVISORS LLC held SCHD?

TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed SCHD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TRAPHAGEN INVESTMENT ADVISORS LLC's current position in SCHD?

As of Q3 2026, TRAPHAGEN INVESTMENT ADVISORS LLC holds 387.25K shares of SCHD (SCHWAB STRATEGIC TR), valued at $12.60M, representing 0.86% of its reported portfolio and ranking #22.

Has TRAPHAGEN INVESTMENT ADVISORS LLC been buying or selling SCHD?

In the latest 13F filing (Q3 2026), TRAPHAGEN INVESTMENT ADVISORS LLC increased its position in SCHD.

Which other funds hold SCHD?

Other major institutional holders of SCHD include SUMITOMO LIFE INSURANCE CO, Rakuten Investment Management, Inc., Cetera Investment Advisers, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.